1. Home
  2. BCAB vs ASYS Comparison

BCAB vs ASYS Comparison

Compare BCAB & ASYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ASYS
  • Stock Information
  • Founded
  • BCAB 2007
  • ASYS 1981
  • Country
  • BCAB United States
  • ASYS United States
  • Employees
  • BCAB N/A
  • ASYS N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ASYS Industrial Machinery/Components
  • Sector
  • BCAB Health Care
  • ASYS Technology
  • Exchange
  • BCAB Nasdaq
  • ASYS Nasdaq
  • Market Cap
  • BCAB 96.2M
  • ASYS 89.7M
  • IPO Year
  • BCAB 2020
  • ASYS N/A
  • Fundamental
  • Price
  • BCAB $2.08
  • ASYS $5.62
  • Analyst Decision
  • BCAB Strong Buy
  • ASYS Hold
  • Analyst Count
  • BCAB 2
  • ASYS 1
  • Target Price
  • BCAB $6.00
  • ASYS N/A
  • AVG Volume (30 Days)
  • BCAB 1.6M
  • ASYS 34.5K
  • Earning Date
  • BCAB 11-08-2024
  • ASYS 12-04-2024
  • Dividend Yield
  • BCAB N/A
  • ASYS N/A
  • EPS Growth
  • BCAB N/A
  • ASYS N/A
  • EPS
  • BCAB N/A
  • ASYS N/A
  • Revenue
  • BCAB N/A
  • ASYS $104,809,000.00
  • Revenue This Year
  • BCAB N/A
  • ASYS N/A
  • Revenue Next Year
  • BCAB N/A
  • ASYS $10.86
  • P/E Ratio
  • BCAB N/A
  • ASYS N/A
  • Revenue Growth
  • BCAB N/A
  • ASYS N/A
  • 52 Week Low
  • BCAB $1.14
  • ASYS $3.37
  • 52 Week High
  • BCAB $4.02
  • ASYS $8.11
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.80
  • ASYS 46.57
  • Support Level
  • BCAB $1.87
  • ASYS $5.59
  • Resistance Level
  • BCAB $2.13
  • ASYS $5.98
  • Average True Range (ATR)
  • BCAB 0.12
  • ASYS 0.25
  • MACD
  • BCAB 0.00
  • ASYS 0.02
  • Stochastic Oscillator
  • BCAB 68.90
  • ASYS 43.75

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; Semiconductor; it designs, manufactures, sells, and services thermal processing equipment and related controls for use by semiconductor manufacturers, and in electronics, automotive, and other industries; and Material and Substrate - it produces consumables and machinery for lapping (fine abrading) and polishing of materials, such as sapphire substrates, optical components, silicon wafers, numerous types of crystal materials, ceramics and metal components.

Share on Social Networks: